A new study reveals a 15 per cent rise in adult ADHD diagnoses between 2020 and 2023, while teenage rates remain stable.

(RTTNews) - French drug major Sanofi (SNY) announced Monday that its Sarclisa has obtained first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma ...

including an increase among adults from 2020 to 2023. The study, published in the journal Psychiatric Research and Clinical Practice, found a significant downward trends in ADHD incidence among ...

We have updated our weighting methodology to improve comparability of our smoking prevalence estimates for 2020 and subsequent years. For more details about this update, see our Adult smoking habits ...

Selecting the most effective medication for an adult with attention deficit hyperactivity disorder (ADHD) can involve trial and error. The best medication for adult ...

The makers of the world’s first gourmet marshmallow advent calendar (there’s a first for everything) are back with a boozy version for adults ... friendly update; in 2020, L’Occitane ...

A new study finds that the desire to be kind to those in need begins much younger than we think.